Genetic HeterogeneityBreastBreast NeoplasmsPedigreeCarcinoma, Ductal, BreastGenetic LinkageReceptors, EstrogenLod ScoreCell Line, TumorReceptor, erbB-2Breast DiseasesTamoxifenGenetic Predisposition to DiseaseGene Expression Regulation, NeoplasticReceptors, ProgesteroneMutationGenotypeMammographyGenetic VariationPrognosisPhenotypeNeoplasm MetastasisGenetic MarkersChromosome MappingNeoplasm InvasivenessTumor Markers, BiologicalRisk FactorsBreast Neoplasms, MaleAntineoplastic Agents, HormonalDNA Mutational AnalysisNeoplasm ProteinsGenes, DominantNeoplasm StagingEarly Detection of CancerMastectomyCase-Control StudiesAntineoplastic AgentsGenes, RecessiveGenes, BRCA1Polymorphism, GeneticPostmenopauseAllelesPolymerase Chain ReactionMolecular Sequence DataChemotherapy, AdjuvantCarcinoma, LobularGene Expression ProfilingConsanguinityCarcinoma, Intraductal, NoninfiltratingMicrosatellite RepeatsMCF-7 CellsBase SequenceRiskMice, NudeHaplotypesTumor Cells, CulturedBreast FeedingSurvival AnalysisChromosomes, Human, Pair 2Reverse Transcriptase Polymerase Chain ReactionDrug Resistance, NeoplasmPremenopauseAntineoplastic Combined Chemotherapy ProtocolsEstrogen Receptor alphaCarcinomaEstrogensImmunohistochemistryExomeMammary Neoplasms, ExperimentalFamily HealthDNA, NeoplasmDisease-Free SurvivalBreast Self-ExaminationDisease ProgressionOvarian NeoplasmsNeoplasms, Hormone-DependentGenetic TestingLymphatic MetastasisCell ProliferationRNA, MessengerAge FactorsFollow-Up StudiesNeoplasmsNeoplasm Recurrence, LocalOdds RatioMenopauseBRCA2 ProteinSurvival RateAge of OnsetHeterozygoteCohort StudiesProspective StudiesHomozygoteRisk AssessmentBRCA1 ProteinGenes, BRCA2Lung NeoplasmsPolymorphism, Single NucleotidePenetranceChromosomes, Human, Pair 19